Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistent

The COVID-19 Genomics UK (COG-UK) Consortium; David J Pascall; Elen Vink; Rachel Blacow; Naomi Bulteel; Alasdair Campbell; Robyn Campbell; Sarah Clifford; Chris Davis; Ana da Silva Filipe; Noha El Sakka; Ludmila Fjodorova; Ruth Forrest; Emily Goldstein; Rory Gunson; John Haughney; Matthew T G Holden; Patrick Honour; Joseph Hughes; Edward James; Tim Lewis; Oscar MacLean; Martin McHugh; Guy Mollett; Tommy Nyberg; Yusuke Onishi; Ben Parcell; Surajit Ray; David L Robertson; Shaun R Seaman; Sharif Shabaan; James G Shepherd; Katherine Smollett; Kate Templeton; Elizabeth Wastnedge; Craig Wilkie; Thomas Williams; Emma C Thomson; Matthew Bashton; Darren Smith; Andrew Nelson; Gregory R. Young

doi:10.1016/j.jinf.2023.05.019

Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistent

The COVID-19 Genomics UK (COG-UK) Consortium, David J Pascall, Elen Vink, Rachel Blacow, Naomi Bulteel, Alasdair Campbell, Robyn Campbell, Sarah Clifford, Chris Davis, Ana da Silva Filipe, Noha El Sakka, Ludmila Fjodorova, Ruth Forrest, Emily Goldstein, Rory Gunson, John Haughney, Matthew T G Holden, Patrick Honour, Joseph Hughes, Edward JamesTim Lewis, Oscar MacLean, Martin McHugh, Guy Mollett, Tommy Nyberg, Yusuke Onishi, Ben Parcell, Surajit Ray, David L Robertson, Shaun R Seaman, Sharif Shabaan, James G Shepherd, Katherine Smollett, Kate Templeton, Elizabeth Wastnedge, Craig Wilkie, Thomas Williams, Emma C Thomson, Matthew Bashton, Darren Smith, Andrew Nelson, Gregory R. Young

Applied Sciences

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

OBJECTIVES: To determine how the intrinsic severity of successively dominant SARS-CoV-2 variants changed over the course of the pandemic.

METHODS: A retrospective cohort analysis in the NHS Greater Glasgow and Clyde (NHS GGC) Health Board. All sequenced non-nosocomial adult COVID-19 cases in NHS GGC with relevant SARS-CoV-2 lineages (B.1.177/Alpha, Alpha/Delta, AY.4.2 Delta/non-AY.4.2 Delta, non-AY.4.2 Delta/Omicron, and BA.1 Omicron/BA.2 Omicron) during analysis periods were included. Outcome measures were hospital admission, ICU admission, or death within 28 days of positive COVID-19 test. We report the cumulative odds ratio; the ratio of the odds that an individual experiences a severity event of a given level vs all lower severity levels for the resident and the replacement variant after adjustment.

RESULTS: After adjustment for covariates, the cumulative odds ratio was 1.51 (95% CI: 1.08-2.11) for Alpha versus B.1.177, 2.09 (95% CI: 1.42-3.08) for Delta versus Alpha, 0.99 (95% CI: 0.76-1.27) for AY.4.2 Delta versus non-AY.4.2 Delta, 0.49 (95% CI: 0.22-1.06) for Omicron versus non-AY.4.2 Delta, and 0.86 (95% CI: 0.68-1.09) for BA.2 Omicron versus BA.1 Omicron.

CONCLUSIONS: The direction of change in intrinsic severity between successively emerging SARS-CoV-2 variants was inconsistent, reminding us that the intrinsic severity of future SARS-CoV-2 variants remains uncertain.

Original language	English
Pages (from-to)	128-135
Number of pages	8
Journal	Journal of Infection
Volume	87
Issue number	2
Early online date	1 Jun 2023
DOIs	https://doi.org/10.1016/j.jinf.2023.05.019
Publication status	Published - 1 Aug 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jinf.2023.05.019Licence: CC BY

1-s2.0-S0163445323002979-mainFinal published version, 2.6 MBLicence: CC BY

Cite this

The COVID-19 Genomics UK (COG-UK) Consortium, Pascall, D. J., Vink, E., Blacow, R., Bulteel, N., Campbell, A., Campbell, R., Clifford, S., Davis, C., da Silva Filipe, A., El Sakka, N., Fjodorova, L., Forrest, R., Goldstein, E., Gunson, R., Haughney, J., Holden, M. T. G., Honour, P., Hughes, J., ... Young, G. R. (2023). Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistent. Journal of Infection, 87(2), 128-135. https://doi.org/10.1016/j.jinf.2023.05.019

@article{21419b909b4a4b9bbf0b619e9001ba7a,

title = "Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistent",

abstract = "OBJECTIVES: To determine how the intrinsic severity of successively dominant SARS-CoV-2 variants changed over the course of the pandemic.METHODS: A retrospective cohort analysis in the NHS Greater Glasgow and Clyde (NHS GGC) Health Board. All sequenced non-nosocomial adult COVID-19 cases in NHS GGC with relevant SARS-CoV-2 lineages (B.1.177/Alpha, Alpha/Delta, AY.4.2 Delta/non-AY.4.2 Delta, non-AY.4.2 Delta/Omicron, and BA.1 Omicron/BA.2 Omicron) during analysis periods were included. Outcome measures were hospital admission, ICU admission, or death within 28 days of positive COVID-19 test. We report the cumulative odds ratio; the ratio of the odds that an individual experiences a severity event of a given level vs all lower severity levels for the resident and the replacement variant after adjustment.RESULTS: After adjustment for covariates, the cumulative odds ratio was 1.51 (95% CI: 1.08-2.11) for Alpha versus B.1.177, 2.09 (95% CI: 1.42-3.08) for Delta versus Alpha, 0.99 (95% CI: 0.76-1.27) for AY.4.2 Delta versus non-AY.4.2 Delta, 0.49 (95% CI: 0.22-1.06) for Omicron versus non-AY.4.2 Delta, and 0.86 (95% CI: 0.68-1.09) for BA.2 Omicron versus BA.1 Omicron.CONCLUSIONS: The direction of change in intrinsic severity between successively emerging SARS-CoV-2 variants was inconsistent, reminding us that the intrinsic severity of future SARS-CoV-2 variants remains uncertain.",

keywords = "Alpha variant, COVID-19, Delta variant, Intrinsic severity, Omicron variant, SARS-CoV-2",

author = "{The COVID-19 Genomics UK (COG-UK) Consortium} and Pascall, {David J} and Elen Vink and Rachel Blacow and Naomi Bulteel and Alasdair Campbell and Robyn Campbell and Sarah Clifford and Chris Davis and {da Silva Filipe}, Ana and {El Sakka}, Noha and Ludmila Fjodorova and Ruth Forrest and Emily Goldstein and Rory Gunson and John Haughney and Holden, {Matthew T G} and Patrick Honour and Joseph Hughes and Edward James and Tim Lewis and Oscar MacLean and Martin McHugh and Guy Mollett and Tommy Nyberg and Yusuke Onishi and Ben Parcell and Surajit Ray and Robertson, {David L} and Seaman, {Shaun R} and Sharif Shabaan and Shepherd, {James G} and Katherine Smollett and Kate Templeton and Elizabeth Wastnedge and Craig Wilkie and Thomas Williams and Thomson, {Emma C} and Matthew Bashton and Darren Smith and Andrew Nelson and Young, {Gregory R.}",

note = "Funding Information: This work was supported by UKRI through the JUNIPER consortium (grant number MR/V038613/1 , https://maths.org/juniper/ ); the Medical Research Council (MRC) (grant numbers MC UU 12014/12, MC UU 00002/11 , https://www.ukri.org/councils/mrc/ ); the G2P-UK National Virology Consortium (grant number MR/W005611/1 , https://www.ukri.org ). The funders had no input on the study design and analysis. Matthew Bashton, Andrew Nelson, Clare McCann, Greg Young and Darren Smith are members of the COVID-19 Genomics UK consortium.",

year = "2023",

month = aug,

day = "1",

doi = "10.1016/j.jinf.2023.05.019",

language = "English",

volume = "87",

pages = "128--135",

journal = "Journal of Infection",

issn = "0163-4453",

publisher = "W.B. Saunders",

number = "2",

}

The COVID-19 Genomics UK (COG-UK) Consortium, Pascall, DJ, Vink, E, Blacow, R, Bulteel, N, Campbell, A, Campbell, R, Clifford, S, Davis, C, da Silva Filipe, A, El Sakka, N, Fjodorova, L, Forrest, R, Goldstein, E, Gunson, R, Haughney, J, Holden, MTG, Honour, P, Hughes, J, James, E, Lewis, T, MacLean, O, McHugh, M, Mollett, G, Nyberg, T, Onishi, Y, Parcell, B, Ray, S, Robertson, DL, Seaman, SR, Shabaan, S, Shepherd, JG, Smollett, K, Templeton, K, Wastnedge, E, Wilkie, C, Williams, T, Thomson, EC, Bashton, M , Smith, D , Nelson, A & Young, GR 2023, 'Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistent', Journal of Infection, vol. 87, no. 2, pp. 128-135. https://doi.org/10.1016/j.jinf.2023.05.019

TY - JOUR

T1 - Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistent

AU - The COVID-19 Genomics UK (COG-UK) Consortium

AU - Pascall, David J

AU - Vink, Elen

AU - Blacow, Rachel

AU - Bulteel, Naomi

AU - Campbell, Alasdair

AU - Campbell, Robyn

AU - Clifford, Sarah

AU - Davis, Chris

AU - da Silva Filipe, Ana

AU - El Sakka, Noha

AU - Fjodorova, Ludmila

AU - Forrest, Ruth

AU - Goldstein, Emily

AU - Gunson, Rory

AU - Haughney, John

AU - Holden, Matthew T G

AU - Honour, Patrick

AU - Hughes, Joseph

AU - James, Edward

AU - Lewis, Tim

AU - MacLean, Oscar

AU - McHugh, Martin

AU - Mollett, Guy

AU - Nyberg, Tommy

AU - Onishi, Yusuke

AU - Parcell, Ben

AU - Ray, Surajit

AU - Robertson, David L

AU - Seaman, Shaun R

AU - Shabaan, Sharif

AU - Shepherd, James G

AU - Smollett, Katherine

AU - Templeton, Kate

AU - Wastnedge, Elizabeth

AU - Wilkie, Craig

AU - Williams, Thomas

AU - Thomson, Emma C

AU - Bashton, Matthew

AU - Smith, Darren

AU - Nelson, Andrew

AU - Young, Gregory R.

N1 - Funding Information: This work was supported by UKRI through the JUNIPER consortium (grant number MR/V038613/1 , https://maths.org/juniper/ ); the Medical Research Council (MRC) (grant numbers MC UU 12014/12, MC UU 00002/11 , https://www.ukri.org/councils/mrc/ ); the G2P-UK National Virology Consortium (grant number MR/W005611/1 , https://www.ukri.org ). The funders had no input on the study design and analysis. Matthew Bashton, Andrew Nelson, Clare McCann, Greg Young and Darren Smith are members of the COVID-19 Genomics UK consortium.

PY - 2023/8/1

Y1 - 2023/8/1

N2 - OBJECTIVES: To determine how the intrinsic severity of successively dominant SARS-CoV-2 variants changed over the course of the pandemic.METHODS: A retrospective cohort analysis in the NHS Greater Glasgow and Clyde (NHS GGC) Health Board. All sequenced non-nosocomial adult COVID-19 cases in NHS GGC with relevant SARS-CoV-2 lineages (B.1.177/Alpha, Alpha/Delta, AY.4.2 Delta/non-AY.4.2 Delta, non-AY.4.2 Delta/Omicron, and BA.1 Omicron/BA.2 Omicron) during analysis periods were included. Outcome measures were hospital admission, ICU admission, or death within 28 days of positive COVID-19 test. We report the cumulative odds ratio; the ratio of the odds that an individual experiences a severity event of a given level vs all lower severity levels for the resident and the replacement variant after adjustment.RESULTS: After adjustment for covariates, the cumulative odds ratio was 1.51 (95% CI: 1.08-2.11) for Alpha versus B.1.177, 2.09 (95% CI: 1.42-3.08) for Delta versus Alpha, 0.99 (95% CI: 0.76-1.27) for AY.4.2 Delta versus non-AY.4.2 Delta, 0.49 (95% CI: 0.22-1.06) for Omicron versus non-AY.4.2 Delta, and 0.86 (95% CI: 0.68-1.09) for BA.2 Omicron versus BA.1 Omicron.CONCLUSIONS: The direction of change in intrinsic severity between successively emerging SARS-CoV-2 variants was inconsistent, reminding us that the intrinsic severity of future SARS-CoV-2 variants remains uncertain.

AB - OBJECTIVES: To determine how the intrinsic severity of successively dominant SARS-CoV-2 variants changed over the course of the pandemic.METHODS: A retrospective cohort analysis in the NHS Greater Glasgow and Clyde (NHS GGC) Health Board. All sequenced non-nosocomial adult COVID-19 cases in NHS GGC with relevant SARS-CoV-2 lineages (B.1.177/Alpha, Alpha/Delta, AY.4.2 Delta/non-AY.4.2 Delta, non-AY.4.2 Delta/Omicron, and BA.1 Omicron/BA.2 Omicron) during analysis periods were included. Outcome measures were hospital admission, ICU admission, or death within 28 days of positive COVID-19 test. We report the cumulative odds ratio; the ratio of the odds that an individual experiences a severity event of a given level vs all lower severity levels for the resident and the replacement variant after adjustment.RESULTS: After adjustment for covariates, the cumulative odds ratio was 1.51 (95% CI: 1.08-2.11) for Alpha versus B.1.177, 2.09 (95% CI: 1.42-3.08) for Delta versus Alpha, 0.99 (95% CI: 0.76-1.27) for AY.4.2 Delta versus non-AY.4.2 Delta, 0.49 (95% CI: 0.22-1.06) for Omicron versus non-AY.4.2 Delta, and 0.86 (95% CI: 0.68-1.09) for BA.2 Omicron versus BA.1 Omicron.CONCLUSIONS: The direction of change in intrinsic severity between successively emerging SARS-CoV-2 variants was inconsistent, reminding us that the intrinsic severity of future SARS-CoV-2 variants remains uncertain.

KW - Alpha variant

KW - COVID-19

KW - Delta variant

KW - Intrinsic severity

KW - Omicron variant

KW - SARS-CoV-2

UR - http://www.scopus.com/inward/record.url?scp=85163078778&partnerID=8YFLogxK

U2 - 10.1016/j.jinf.2023.05.019

DO - 10.1016/j.jinf.2023.05.019

M3 - Article

C2 - 37270070

VL - 87

SP - 128

EP - 135

JO - Journal of Infection

JF - Journal of Infection

SN - 0163-4453

IS - 2

ER -

Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistent

Abstract

UN SDGs

Access to Document

Other files and links

Cite this